JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304838200 on August 4, 2003

J. Biol. Chem., Vol. 278, Issue 42, 41237-41245, October 17, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/42/41237    most recent
M304838200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mataraza, J. M.
Right arrow Articles by Sacks, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mataraza, J. M.
Right arrow Articles by Sacks, D. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

IQGAP1 Promotes Cell Motility and Invasion*

Jennifer M. Mataraza {ddagger}, Michael W. Briggs {ddagger}, Zhigang Li {ddagger}, Alan Entwistle §, Anne J. Ridley § ¶ and David B. Sacks {ddagger} ||

From the {ddagger}Department of Pathology, Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts 02115, §Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, 91 Riding House Street, London W1W 7BS, United Kingdom, and the Department of Biochemistry and Molecular Biology, University College London, London WC1E 6BT, United Kingdom

Received for publication, May 8, 2003 , and in revised form, July 18, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The dynamic processes of cell migration and invasion are largely coordinated by Rho family GTPases. The scaffolding protein IQGAP1 binds to Cdc42, increasing the amount of active Cdc42 both in vitro and in cells. Here we show that overexpression of IQGAP1 in mammalian cells enhances cell migration in a Cdc42- and Rac1-dependent manner. Importantly, cell motility was significantly decreased both by knock down of endogenous IQGAP1 using small interfering RNA and by transfection of a dominant negative IQGAP1 construct, IQGAP1{Delta}GRD. Cell invasion was similarly altered by manipulating intracellular IQGAP1 concentrations. Moreover, invasion mediated by constitutively active Cdc42 was attenuated by IQGAP1{Delta}GRD. Thus, IQGAP1 has a fundamental role in cell motility and invasion.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell migration is a multistep process that is essential for normal development, angiogenesis, wound repair, and metastasis (1). Specifically, it involves protrusion of the plasma membrane at the leading edge, configuration of new sites of adhesion to the extracellular matrix at the front, the release of old adhesions in the back of the cell, and finally, contraction of actomyosin-based cytoskeletal filaments in the cell body (2). Coordination of the actin cytoskeleton, adhesion molecules, and microtubules is required for cell movement; this function is largely orchestrated by the Rho family of GTPases. For example, Cdc42 and Rac, which regulate the production of filopodia and lamellipodia, respectively (3, 4), are important for mediating new protrusions and adhesions at the cell periphery during migration.

Cdc42 and Rac1 participate in cell function by interacting with a diverse array of proteins (5). One of these, IQGAP1, regulates cytoskeletal function by integrating multiple targets, including Cdc42 and Rac1 (6, 7), actin (8, 9), calmodulin (7, 10), and CLIP-170 (11). We previously documented that IQGAP1 inhibits the intrinsic GTPase activity of Cdc42 (10), thereby significantly increasing levels of active Cdc42 in cells (12). In addition, a dominant negative IQGAP1 construct, IQGAP1{Delta}GRD,1 substantially reduced active Cdc42, preventing the formation of filopodia (12). Moreover, in vivo analysis revealed that IQGAP1 induced superficial ectodermal lesions in Xenopus embryos, indicating that IQGAP1 is likely to affect cytoskeletal architecture and cell adhesion (13).

We therefore hypothesized that IQGAP1 may play a role in mediating cell motility and invasion. Here we demonstrate that IQGAP1 overexpression significantly increased cell migration in several different cell types. IQGAP1 also increased cell speed on both glass and plastic substrata. Dominant negative Cdc42 and Rac1, but not RhoA, inhibited the IQGAP1-mediated increase in motility. Moreover, cell migration was significantly slowed by both IQGAP1{Delta}GRD and knock down of IQGAP1 by both transient and stable expression of small interfering RNA (siRNA) for IQGAP1. Stable overexpression of IQGAP1 also led to a significant increase in cell invasive capacity. These data imply that IQGAP1 is an important component of cell motility and invasion.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell Culture and Transfection—Cells were cultured and transfected as described (14). MCF-7 cells which stably overexpress either pcDNA3 (MCF/V) or pcDNA3-Myc-IQGAP1 (MCF/I) have been described previously; MCF/I cells have 3-fold more IQGAP1 than MCF/V cells (12).

Plasmid Constructs—Wild type human IQGAP1 in pcDNA3 vector was used (6, 10). The construction of IQGAP1{Delta}GRD (residues 1122–1324 deleted) and dual promoter plasmids co-expressing green fluorescent protein (GFP) and IQGAP1 or IQGAP1{Delta}GRD have been described previously (12, 13, 15). GST fusion proteins were expressed in Escherichia coli and isolated with glutathione-Sepharose as described (10). Myc-tagged forms of N17Cdc42, N17RhoA, and N17Rac1 (3) were kindly provided by Alan Hall (University College London).

siRNA—siRNAs were engineered by oligonucleotide hybridization as 19-mer duplexes with 3-nucleotide spacer loops and were targeted to the following regions of IQGAP1 mRNA (with +1 representing the first nucleotide of the start codon, gttctacgggaagtaattg): siRNA 2, 145–163; siRNA 3, 315–333; siRNA 5, 2061–2079; siRNA 6, 2551–2569; siRNA 8, 4959–4977; siRNA 9, 6705–6723. Each oligonucleotide pair was designed to produce restriction site overhangs upon annealing (BbsIatthe 5'-end and XbaI at the 3'-end) for cloning into vector mU6pro (16) (kindly provided by David Turner (University of Michigan)) digested with the same enzymes. mU6pro and mU6siRNA 2, 3, 5, 6, 8, or 9 were transfected into MCF-7 cells, and lysates were prepared 48 h later for analysis by Western blotting (12).

Stable expression of siRNA for IQGAP1 was performed with the pSUPER (SUPpression of Endogenous RNA) retroviral vector construct (OligoEngine) (17). Oligonucleotide IQ8 was synthesized with a 5' BamHI and 3' HindIII site to directionally clone into the BglII and HindIII sites of pSUPER. The H1 promoter and targeting inserts were excised from pSUPER-IQ8 and cloned into the self-inactivating murine stem cell virus pMSCV to generate pRETRO-SUPER-IQ8. Replication-defective pseudotyped amphotropic retrovirus was produced by cotransfecting HEK-293H cells with pKat, pCMV-VSV-G, and pRETRO-SUPER-IQ8. MCF-7 cells were infected with culture supernatants containing active retrovirus for 6 h by standard centrifugation-mediated infection (18). After recovery for 24 h, stable integrants were selected with 1 µg/ml puromycin. One stable cell line, termed MCF-siIQ8, was chosen for these studies.

Wound Healing Assay and Time Lapse Microscopy—HEK-293H cells were transiently transfected with a dual promoter plasmid that expresses both GFP and either wild type IQGAP1, IQGAP1{Delta}GRD, or pcDNA3 vector (12, 15). Cells were plated onto Lab-Tek II chambered coverglass (Nalge Nunc International) in DMEM containing 10% fetal bovine serum. 24 h after plating, cells were scraped with a 26-gauge needle and rinsed twice with DMEM containing 10% fetal bovine serum to remove dislodged cells, and images were captured immediately using a Zeiss LSM 510W upright confocal microscope. Cells were imaged again 8 or 14 h after wounding.

For time lapse microscopy, MCF/I and MCF/V cells were plated into 35-mm plastic Petri dishes with (Mat Tek Corp.) or without (Nalge Nunc International) a central poly-D-lysine-coated glass coverslip insert and grown to confluence in DMEM containing 10% fetal bovine serum. Cell monolayers were wounded with a 200-µl disposable plastic pipette tip (Sarstedt), a layer of embryo-tested mineral oil (Sigma) was spread across the medium to prevent evaporation, and the dishes were then placed in a chamber affixed to the stage of an Axiovert 135 inverted microscope (Carl Zeiss) and maintained at 37 °C with an atmosphere containing 5% CO2. Sequences of time lapse images were collected through a 20x objective and projected onto a KPM1E CCD camera (Hitachi Denshi Ltd.) using a 10%/90% pellicle beam splitter (Melles Griot). The acquisition of image data and synchronization of the illumination were controlled by Tempus Meteor software (Kinetic Imaging). Images were collected every 4 min for 14 h.

Active Cdc42 and Active Rac1 Assays—Measurement of active Cdc42 was performed essentially as previously described (12, 19). Briefly, HEK-293H cells were washed twice in PBS and lysed in 500 µl of buffer A (20 mM Hepes, pH 7.4, 150 mM NaCl, 1% (v/v) Nonidet P-40, 20 mM NaF, 1 mM MgCl2, and protease inhibitors) containing 20 µM GTP. Cell lysates were quick frozen, thawed, sonicated at 4 °C, and subjected to centrifugation at 15,000 x g for 10 min at 4 °C. Equal amounts of lysate were precleared for 1 h at 4 °C with 40 µl of glutathione-Sepharose. An equal aliquot of each sample (50 µg of total protein) was examined directly as whole cell lysate, and equal amounts of protein lysate were incubated with 40 µg of GST-WASP-GBD (for active Cdc42) or GST-PAK-CRIB (Cdc42-Rac-interactive binding) (for active Rac1) for 2 h at 4 °C. Following collection of complexes with glutathione-Sepharose, the beads were washed six times with buffer A. SDS-PAGE was performed and proteins were transferred to polyvinylidene difluoride membranes. Blots were probed with anti-Cdc42 or anti-Rac1 antibodies (BD Biosciences), followed by horseradish peroxidase-conjugated sheep-anti-mouse antibodies, and ECL was used for detection.

Cell Speed and Cell Division Analysis—The coordinates of MCF/V and MCF/I cells were recorded in Excel data files (Microsoft Corp.) semiautomatically from each frame of time lapse data sequentially using Motion Analysis software version 1.1 (Kinetic Imaging) employing a minimum difference over a region-of-interest algorithm searching with eight-way connectivity. The speeds were calculated using a series of Mathematica notebooks (20), and the significance of the results was established through analysis of variance and the method of Sheffé's multiple comparisons. The number of mitotic figures in each time lapse sequence was counted manually during the tracking process.

Migration and Invasion Assays—Migration assays were performed as previously described (21). Briefly, Transwells with 8-µm pores were placed in 12-well tissue culture plates (Corning Glass), and the underside of the membranes was coated with human collagen I at 37 °C (Collaborative Biomedical Products). Collagen was removed after 18 h and replaced with DMEM. Cells were trypsinized, washed once in DMEM, and counted with a hemacytometer. Cells were resuspended at a concentration of 200,000/ml in DMEM containing 5 mg/ml bovine serum albumin, and 600 µl of this suspension was added to the top chamber of the Transwell, whereas 600 µl of DMEM was added to the lower chamber. After 16 h, assays were terminated by wiping the top of the Transwell membrane with a cotton swab to remove nonmigratory cells. Membranes were then fixed and stained with DiffQuick (Baxter Scientific Products) and mounted on glass slides. Quantification of cells was performed by counting four microscope fields using a 10x objective (at least 600 cells were counted for each Transwell membrane).

For invasion assays, cells were serum-starved overnight in DMEM. Transwells were purchased precoated with Matrigel (Corning Glass), and 500 µl of DMEM containing 10% fetal bovine serum was placed in the lower chamber. Cells were trypsinized, washed, counted, and resuspended at a concentration of 200,000/ml in DMEM. 500 µl of this suspension was added to the top chamber of the Transwell. After 24 h at 37 °C, assays were terminated, and cells were quantified as described above for migration analysis. (at least 400 cells were counted in each well).

Microinjection—Subconfluent Swiss 3T3 cells were grown on ethanol-washed glass slides and microinjected with GST or GST-IQGAP1 (>90% pure; data not shown) using an Eppendorf microinjector with a Zeiss Axiovert microscope essentially as described (4). Cells maintained at 37 °C under 5% CO2 were imaged at 60-s intervals by time lapse video microscopy.

Immunocytochemistry and Confocal Microscopy—Cells were grown to confluence on Lab Tek II chambered glass slides and processed for immunocytochemistry as described (12). Images were generated by confocal laser scanning with a Zeiss LSM 510W upright confocal microscope using separate channels for red and green image collection. Quantification of green and red channel pixel intensity (collection at 488 and 543 nm (BP505-550 and LP560)) was performed using the Zeiss LSM 510 Meta Excitation system.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
IQGAP1 Localizes at the Leading Edge of Migrating Cells— Previous studies from our laboratory indicate that IQGAP1 is a regulator of the actin cytoskeleton (12). Specifically, overexpression of IQGAP1 increases levels of active Cdc42, leading to increased production of filopodia. To investigate a possible role for IQGAP1 in cell motility, GST-IQGAP1 was microinjected into Swiss 3T3 cells. Time lapse imaging revealed that IQGAP1 induced filopodium formation predominantly in one area of the cell, followed by directional extension of lamellipodia (Fig. 1A). This phenotype was not observed with a 10-fold molar excess of GST alone. These results are very similar to the formation of filopodia and subsequent lamellipodia seen in cells microinjected with Cdc42 (4).



View larger version (49K):
[in this window]
[in a new window]
 
FIG. 1.
IQGAP1 induces filopodium formation and localizes at the leading edge of migrating cells. A, subconfluent Swiss 3T3 cells were microinjected with GST or GST-IQGAP1. Images at selected time points (minutes after injection) are shown. Examples of filopodia (straight arrows) and lamellipodia (arrowheads) are indicated. B and C, confluent Swiss 3T3 cells were wounded and 8 h later were probed with anti-IQGAP1 antibodies (IQGAP1) and rhodamine-phalloidin (Actin). Images, taken at x63 (B)or x100 (C) magnification, are representative of at least 3–5 independent experiments. The arrows indicate the location of IQGAP1; the arrowheads indicate the direction of cell movement. D, confluent MCF-7 cells were transfected with GFP (GFP) and wounded. After 8 h, cells were fixed and probed with anti-IQGAP1 antibodies (IQGAP1, red). Pixel intensities of the red (IQGAP1) and green (GFP) channels (488 and 543 nm, respectively) were quantified in an ~8-µm section, starting at the leading edge toward the back of a single cell expressing GFP (arrow). The plot in the bottom panel indicates red and green pixel intensity (y axis) over the ~8-µm section (x axis; distance in µm). A representative image is shown.

 

To investigate whether the localization of IQGAP1 is consistent with a role in migration, we examined the location of endogenous IQGAP1 in migrating Swiss 3T3 cells. In sessile cells, IQGAP1 is normally distributed throughout the cytoplasm, with accumulation at cell-cell junctions and in the Golgi (14, 22). After wounding a confluent monolayer of cells, immunostaining showed that IQGAP1 was localized at the leading edge of migrating cells (Fig. 1, B and C). To confirm that IQGAP1 is enriched at the leading edge, we transfected MCF-7 cells with GFP and stained for endogenous IQGAP1. Because GFP is distributed throughout the cytoplasm and nucleus, comparison of GFP and IQGAP1 distribution at the front of the cell will reveal whether IQGAP1 accumulates at the leading edge. We quantified pixel intensities of both green (GFP) and red (IQGAP1) channels (collection at 488 and 543 nm, respectively), starting at the front edge and moving toward the back of a single cell along the wound edge. The pixel intensity of GFP was distributed relatively evenly over the distance measured. In contrast, IQGAP1 was increased at the front of the cell (Fig. 1D). These data clearly demonstrate that endogenous IQGAP1 localization is enhanced at the leading edge of migrating cells.

IQGAP1 Increases Cell Migration—The data in Fig. 1 suggested that IQGAP1 could play a role in cell motility. We employed several strategies to examine this hypothesis. Confluent monolayers of MCF-7 cells stably transfected with pcDNA3 vector (MCF/V) or pcDNA3-IQGAP1 (termed MCF/I, these cells express IQGAP1 at 3 times the levels expressed in MCF/V cells) (12) were wounded, and cells along the wound edge were imaged by time lapse microscopy over a 12-h time period (Fig. 2A). Both MCF/I and MCF/V cells migrated into the wound primarily by cell spreading, not cell division (Fig. 2A). In addition, some MCF/I cells at the wound edge spread out into the wound space and nearly detached from their neighbors (Fig. 2A, arrowhead). This behavior was not observed with MCF/V cells. The migration speed of MCF/I cells was significantly faster than MCF/V cells on both glass and plastic (Table I), and this led to more rapid healing of wounded monolayers. MCF/V cells reduced the width of the wound (~200 µm) by 37.7 ± 7.2% (mean ± S.E., n = 3, p < 0.01) after 14 h (Fig. 2, B and C) (note that MCF-7 cells are not very motile) (23). In contrast, MCF/I cells completely filled the wound in the same time interval. This difference was not due merely to increased proliferation of MCF/I cells, since the number of cells entering mitosis was not increased (Table I). Moreover, the growth rate of MCF/I cells was indistinguishable from that of MCF/V cells (data not shown).



View larger version (61K):
[in this window]
[in a new window]
 
FIG. 2.
IQGAP1 enhances migration of MCF-7 cells. Wound healing of MCF-7 cells stably expressing either vector (MCF/V) or IQGAP1 (MCF/I) was examined. A, MCF/I cells (upper panel) and MCF/V cells (lower panel) plated onto poly-D-lysine-coated glass coverslips were wounded, and images were collected every 4 min for a period of 13–15 h starting 10–15 min after scraping (0 h). The arrows indicate examples of cells that clearly displayed an increase in spread area during the process of wound repair. The arrowheads indicate an example of a cell at the wound edge spread out into the wound space and nearly detached from neighboring cells. B, cells, plated onto slides, were scraped with a 26-gauge needle. Images were captured immediately after rinsing at 0 h, and at 14 h. Data are representative of at least three independent experimental determinations. Scale bar, 40 µm. C, percentage of wound closure was quantified by measuring the average width of the wounds from three separate experiments; data are expressed relative to the wound closure of MCF/I cells. D, migration of MCF/V and MCF/I cells through Transwell pores was quantified by counting fields of migratory cells under a light microscope. Data, expressed relative to migration of MCF/V cells, represent the means ± S.E. (n = 16). *, significantly different from MCF/V (p < 0.005).

 

View this table:
[in this window]
[in a new window]
 
TABLE I
Mean cell speed of MCF/I and MCF/V cells

Confluent monolayers of MCF/I and MCF/V cells were wounded and imaged by time lapse microscopy for 14 h. Each mean value represents the cumulated results from two independent experiments ± SD. * and **, these pairs of values are significantly different, p < 0.01.

 

Closure of the wound by MCF/I cells in 14 h is consistent with the data in Table I. The distance moved by MCF/V cells in Fig. 2B, however, is less than that predicted from the measured mean speed (Table I). This apparent disparity may reflect different experimental conditions and paramaters measured. Mean cell speed (Table I) measures displacement of nuclei, which includes movement in all directions including sideways movement that does not contribute to wound closure, whereas wound healing (Fig. 2, B and C) measures distance covered by the wound edge. In addition, mean cell speed does not take into account the length of forward protrusions, which contributes to the speed of wound closure. Because the increase in cell motility is predominantly via increased cell spreading (Fig. 2A), analysis of cell speed (which tracks nuclei) and cell migration (which involves cell spreading) may not give identical results.

The effect of IQGAP1 on cell motility was confirmed by evaluating migration through Transwell pores. MCF/I cells exhibited a 2.82 ± 0.17-fold (mean ± S.E., n = 16, p < 0.005) greater motility than MCF/V cells (Fig. 2D). Similarly, transient overexpression of IQGAP1 accelerated motility by 1.60 ± 0.07- and 1.67 ± 0.09-fold in HEK-293H cells and highly motile MDA-MB-231 cells, respectively (Fig. 3C).



View larger version (57K):
[in this window]
[in a new window]
 
FIG. 3.
IQGAP1{Delta}GRD decreases cell motility. A, wound healing of HEK-293H cells transiently transfected with a plasmid that expresses both GFP and either vector (V), wild type IQGAP1 (IQGAP1), or IQGAP1{Delta}GRD. Assays were performed as described in the legend to Fig. 2. Data are representative of at least three independent experimental determinations. Scale bar, 40 µm. B, wound closure was quantified as described in the legend to Fig. 2 and is expressed relative to vector-transfected cells. C, migration through Transwells of HEK-293H and MDA-MB-231 cells transiently transfected with vector (V), IQGAP1 (WT), or IQGAP1{Delta}GRD ({Delta}GRD) was examined. Data are expressed relative to the migration of vector-transfected cells and represent the means ± S.E. (n = 4). *, significantly different from vector-transfected cells (p < 0.005). **, significantly different from vector-transfected cells (p < 0.01).

 

IQGAP1{Delta}GRD Reduces Cell Motility—To gain insight into the mechanism by which IQGAP1 enhances cell motility, we utilized IQGAP1{Delta}GRD, which reduces levels of endogenous active Cdc42 (12). HEK-293H cells were transiently transfected with dual promoter vectors that co-express GFP (to easily identify transfected cells) and either IQGAP1 or IQGAP1{Delta}GRD. A pcDNA3 vector expressing GFP was used as a control. Cells transfected with vector or wild type IQGAP1 closed the wound by 8 h (Fig. 3A). By contrast, transfection of IQGAP1{Delta}GRD slowed motility by 85.1 ± 5.3% (mean ± S.E., n = 3, p < 0.001) (Fig. 3, A and B). Nontransfected cells in the upper right quadrant of the IQGAP1{Delta}GRD panel (Fig. 3A, compare 0 and 8 h) appeared to move the same distance as vector-transfected cells. However, when nontransfected cells are adjacent to cells transfected with IQGAP1{Delta}GRD, their ability to migrate seemed to be impaired. The molecular mechanism responsible for this effect, which we have observed repeatedly, is unknown.

Analysis of the effect of IQGAP1{Delta}GRD on cell motility was also examined with the Transwell assay. Transient expression of IQGAP1{Delta}GRD in HEK-293H cells significantly slowed migration (Fig. 3C). To confirm this observation in another cell line, migration assays were performed using MDA-MB-231 cells. Transient transfection of IQGAP1{Delta}GRD dramatically reduced cell motility in this highly motile breast epithelial cell line (Fig. 3C).

Cdc42 and Rac1 Are Necessary for the IQGAP1-mediated Increase in Cell Migration—Wild type IQGAP1 and IQGAP1{Delta}GRD increase and decrease active Cdc42, respectively (12) (Fig. 4A). Similarly, overexpression of IQGAP1 increased levels of active Rac1 in HEK-293H cells. Analogous to its effect on Cdc42, IQGAP1{Delta}GRD reduced the amount of active Rac1 (Fig. 4A). The possible participation of Rho GTPases in IQGAP1-stimulated motility was examined. In cells overexpressing IQGAP1, N17Cdc42 and N17Rac1 completely eliminated the IQGAP1-mediated enhancement of cell motility (Fig. 4B). N17Cdc42 and N17Rac1 reduced migration of MCF/V cells only slightly (Fig. 4B). The latter finding is in agreement with a previous study, which showed that N17Cdc42-expressing Rat1 fibroblasts do not exhibit reduced motility (24). RhoA does not bind to IQGAP1 (6), and N19RhoA did not significantly attenuate IQGAP1-induced motility (Fig. 4B). Expression levels of N17Cdc42, N17Rac1, and N19RhoA, monitored by lysing an aliquot of cells prior to plating for migration assays and Western blotting with anti-Myc antibodies, were found to be similar (data not shown). The finding that N19RhoA did not affect migration was somewhat surprising, since several groups have shown that RhoA is required for cell migration (20, 25). However, N19RhoA does not abrogate the Vav-3-mediated increase in motility of NIH-3T3 cells (26), nor does it affect the migration speed of endothelial cells (27) and thus the relative contribution of RhoA to cell migration differs among various cell types. We also observed that an IQGAP1 mutant unable to bind Cdc42 or Rac1 failed to alter motility of HEK-293H cells (data not shown). Collectively, these data suggest that IQGAP1 increases cell motility in a Cdc42- and Rac1-dependent manner.



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 4.
IQGAP1 increases cell migration in a Cdc42- and Rac-dependent manner. A, HEK-293H cells were transiently transfected with 10 µg of either wild type IQGAP1 (WT), vector (V), or IQGAP1{Delta}GRD ({Delta}GRD). Equal amounts of protein were subjected to SDS-PAGE, and blots were probed with anti-Myc (which detects only transfected IQGAP1) (Myc), anti-Rac1 (Total Rac1), and anti-Cdc42 antibodies (Total Cdc42), followed by horseradish peroxidase-conjugated goat anti-mouse antibodies, and developed with ECL. Equal amounts of protein were also incubated with GST-PAK-CRIB (Active Rac1) or GST-WASP-GBD (Active Cdc42) as described under "Experimental Procedures." Complexes were collected with glutathione-Sepharose and resolved by SDS-PAGE, and Western blots were probed with anti-Rac1 or anti-Cdc42 antibodies. B, MCF/V or MCF/I cells were transfected with equal amounts of vector (V), N17Cdc42, N17Rac1, or N19RhoA. Migration through Transwell pores was assessed as described under "Experimental Procedures." Data represent the means ± S.E. (n = 4). *, significantly different from MCF/V cells transiently transfected with vector (p < 0.005). **, significantly different from MCF/I cells transiently transfected with vector (p < 0.005).

 

Reduction in IQGAP1 Expression Inhibits Cell Motility— siRNA has recently been shown to be an efficient method to specifically knock down individual proteins in mammalian cells (16, 28). Several siRNA oligonucleotides were designed, targeting various regions of IQGAP1. Transient expression of a 19-mer stem-loop oligonucleotide complementary to bp 4959–4977 of IQGAP1 cDNA, termed siRNA 8, reduced IQGAP1 protein levels by over 50% (Fig. 5A). Importantly, reduction of IQGAP1 protein by siRNA 8 significantly retarded the ability of MCF-7 cells to migrate (Fig. 5B). In order to verify the specificity of the siRNA, another oligonucleotide was utilized, termed siRNA 9, which is directed against bp 6705–6723 of IQGAP1. Transfection of siRNA 9 significantly reduced both endogenous IQGAP1 (Fig. 5A) and cell migration through Transwell pores (Fig. 5B). By contrast, siRNAs 2, 3, 5, and 6, which do not reduce IQGAP1 protein expression, had no effect on cell motility (Fig. 5, A and B).



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 5.
Reduction of IQGAP1 by siRNA attenuates cell migration. A, MCF-7 cells were transiently transfected with mU6pro (V) or mU6siRNA 2, 3, 5, 6, 8, or 9 as described under "Experimental Procedures." Equal amounts of protein lysates were analyzed by Western blotting with anti-IQGAP1 and anti-actin antibodies. B, MCF-7 cells were transfected with vector (V), IQGAP1 (WT), or mU6siRNA 2, 3, 5, 6, 8, or 9. Migration data, expressed relative to vector-transfected cells, represent the means ± S.E. (n = 6 for vector, wild type, and mU6siRNA 8, and n = 2 for mU6siRNA 2, 3, 5, 6, and 9). *, significantly different from vector-transfected cells (p < 0.001).

 

We employed a retroviral system to stably integrate siRNA 8 into the genome of MCF-7 cells. IQGAP1 protein expression in these cells (termed MCF-siIQ8 cells) was reduced by 80% (Fig. 6A). Compared with native MCF-7 cells, cell migration of MCF-siIQ8 cells was decreased by 71% (Fig. 6B). Note that the magnitude of reduction of cell migration correlates with the extent of the decrease in IQGAP1 protein levels. These data strongly suggest that IQGAP1 is required for cell motility. The possible contribution of IQGAP2 to cell motility was not addressed in this study, since the protein is expressed primarily in liver (29).



View larger version (14K):
[in this window]
[in a new window]
 
FIG. 6.
Stable expression of siRNA for IQGAP1 reduces cell motility. A, equal amounts of protein lysates from MCF-7 and MCF-siIQ8 cells were analyzed by Western blotting with anti-IQGAP1 and anti-actin antibodies. IQGAP1 protein, quantified by densitometry and corrected for the amount of actin, is expressed relative to MCF-7 cells (n = 2). B, migration of MCF-7 and MCF-siIQ8 cells. Migration data, expressed relative to MCF-7 cells, represent the means ± S.E., n = 3. *, significantly different from MCF-7 cells (p < 0.0001). C, migration of T47D and T47D/V12Cdc42 cells transfected with vector (V) or mU6siRNA 8 (means ± S.E., n = 3). *, significantly different from T47D/V12Cdc42 cells transfected with vector (p < 0.001).

 

Cdc42 is an important component of cell motility. Stable transfection with constitutively active Cdc42 increases migration of T47D cells across collagen (30) (Fig. 6C). Because IQGAP1 appears to function both upstream and downstream of Cdc42 (10, 12, 13), we investigated the function of IQGAP1 in Cdc42-induced cell migration. Knock down of IQGAP1 by siRNA markedly reduced migration of these T47D/V12Cdc42 cells (Fig. 6C), implying that IQGAP1 is necessary for the increased epithelial cell motility produced by Cdc42.

IQGAP1 Enhances Cell Invasion—The enhanced motility induced by IQGAP1 suggested that it could contribute to cell invasion. Analysis revealed that MCF/I cells were significantly more invasive than MCF/V cells (Fig. 7A). By contrast, reduction of endogenous IQGAP1 by siRNA attenuated cell invasion (Fig. 7, A and B). Cdc42 contributes to cell invasion; stable transfection of V12Cdc42 in the modestly invasive T47D cell line enhances invasive capacity by 9-fold (21) (Fig. 7C). Because IQGAP1{Delta}GRD reduced the amount of active Cdc42 and eliminated the morphological changes produced by constitutively active Cdc42 in T47D/V12Cdc42 cells (12), we examined the role of IQGAP1 in Cdc42-induced invasion. Transfecting IQGAP1{Delta}GRD into T47D/V12Cdc42 cells reduced their invasiveness by 54% (Fig. 7C), suggesting that the interaction of IQGAP1 with Cdc42 contributes to cell invasion.



View larger version (14K):
[in this window]
[in a new window]
 
FIG. 7.
IQGAP1 increases invasion. A, invasion of MCF/V and MCF/I cells, transfected with mU6pro (V) or mU6siRNA 8 (siRNA) represents the means ± S.E. (n = 4 for vector, n = 2 for siRNA). *, significantly different from MCF/V cells transfected with vector (p < 0.005). B, invasion of MCF-7 and MCF-siIQ8 cells (mean ± S.E., n = 3). *, significantly different from uninfected MCF-7 cells (p < 0.0001). C, invasion of T47D and T47D/V12Cdc42 cells transfected with vector (V) or IQGAP1{Delta}GRD ({Delta}GRD) (n = 2).

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
This study shows that increasing and decreasing intracellular IQGAP1 concentrations leads to a concomitant augmentation and reduction, respectively, of cell migration. In addition, cells overexpressing IQGAP1 move faster and some cells at the leading edge of the wound tend to move far forward of neighboring cells without detaching.

A complex interaction among many proteins and signaling pathways contributes to cell migration, and Rho GTPases have a prominent role in this process (1). Several lines of evidence suggest that the interaction of IQGAP1 with Cdc42/Rac1 contributes to its effect on cell migration. A dominant negative IQGAP1, which decreases levels of active Cdc42 (12) and active Rac1, significantly decreased cell motility. IQGAP1-stimulated migration was inhibited by dominant negative Rac1 and Cdc42. In addition, dominant negative IQGAP1 attenuated the enhanced invasion produced by constitutively active Cdc42 in T47D/V12Cdc42 cells. Earlier work from our laboratory demonstrated that IQGAP1 is required for active Cdc42 to localize at the plasma membrane (12), and in the current study we show that IQGAP1 localizes at the leading edge. Therefore, we propose that IQGAP1 may influence cell motility by increasing levels of active Cdc42 (and Rac1) at the leading edge of migrating cells.

IQGAP1 was shown to disrupt the E-cadherin-{beta}-catenin complex at cell-cell junctions, thereby reducing cell-cell adhesion (14, 31). We cannot exclude the possibility that attenuation of E-cadherin function contributes to the enhanced migration speed induced by IQGAP1 in MCF-7 cells. However, IQGAP1 increased migration in MDA-MB-231 cells, which lack E-cadherin (14), indicating that in these cells IQGAP1 promotes cell motility independently of E-cadherin.

Collectively, our data provide a possible molecular mechanism underlying the observation by Richard Hynes' group that IQGAP1 gene expression is enhanced in highly metastatic melanoma cells (32). Our findings indicate that IQGAP1 is an integral component of cell motility and participates in Cdc42-induced cell migration and invasion.


    FOOTNOTES
 
* This study was supported in part by NCI, National Institutes of Health, Grant CA75205 (to D. B. S.), Public Health Service Graining Grant HL07627 (to J. M. M.), and the Ludwig Institute for Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

|| To whom correspondence should be addressed: Brigham and Women's Hospital, Thorn 530, 75 Francis St., Boston, MA 02115. Tel.: 617-732-6627; Fax: 617-278-6921; E-mail: dsacks{at}rics.bwh.harvard.edu.

1 The abbreviations used are: IQGAP1{Delta}GRD, IQGAP1 lacking a portion of the Ras-GTPase-activating protein-related domain; GST, glutathione S-transferase; GFP, green fluorescent protein; siRNA, small interfering RNA; DMEM, Dulbecco's modified Eagle's medium. Back


    ACKNOWLEDGMENTS
 
We are grateful to Alan Hall (University College London) for generously donating the dominant negative RhoA, Rac1, and Cdc42 constructs, to Patricia Keely (University of Wisconsin) for the T47D cell lines, to Yi Zheng (University of Cincinnati) for the GST-WASP, to David Turner (University of Michigan) for the mU6pro vector, and to Edward Manser (Institute of Molecular and Cellular Biology, Singapore) and Christine Hall (University College London) for the GST-PAK-CRIB. We thank Louis Lim (University College London) for graciously hosting D. B. S. in his laboratory, where some of the work was performed; Christine Hall and Matthew Brown for patient instruction in microinjection; Sabine Klischies and Ritu Garg for technical assistance; and Elizabeth Sullivan for assistance with RNA interference.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ridley, A. J. (2001) J. Cell Sci. 114, 2713–2722[Abstract/Free Full Text]
  2. Ridley, A. (2000) Nature 406, 466–467[CrossRef][Medline] [Order article via Infotrieve]
  3. Nobes, C. D., and Hall, A. (1995) Cell 81, 53–62[CrossRef][Medline] [Order article via Infotrieve]
  4. Kozma, R., Ahmed, S., Best, A., and Lim, L. (1995) Mol. Cell. Biol. 15, 1942–1952[Abstract]
  5. Hall, A. (1998) Science 279, 509–514[Abstract/Free Full Text]
  6. Hart, M. J., Callow, M. G., Souza, B., and Polakis, P. (1996) EMBO J. 15, 2997–3005[Medline] [Order article via Infotrieve]
  7. Joyal, J. L., Annan, R. S., Ho, Y. D., Huddleston, M. E., Carr, S. A., Hart, M. J., and Sacks, D. B. (1997) J. Biol. Chem. 272, 15419–15425[Abstract/Free Full Text]
  8. Erickson, J. W., Cerione, R. A., and Hart, M. J. (1997) J. Biol. Chem. 272, 24443–24447[Abstract/Free Full Text]
  9. Mateer, S. C., McDaniel, A. E., Nicolas, V., Habermacher, G. M., Lin, M. J., Cromer, D. A., King, M. E., and Bloom, G. S. (2002) J. Biol. Chem. 277, 12324–12333[Abstract/Free Full Text]
  10. Ho, Y. D., Joyal, J. L., Li, Z., and Sacks, D. B. (1999) J. Biol. Chem. 274, 464–470[Abstract/Free Full Text]
  11. Fukata, M., Watanabe, T., Noritake, J., Nakagawa, M., Yamaga, M., Kuroda, S., Matsuura, Y., Iwamatsu, A., Perez, F., and Kaibuchi, K. (2002) Cell 109, 873–885[CrossRef][Medline] [Order article via Infotrieve]
  12. Swart-Mataraza, J. M., Li, Z., and Sacks, D. B. (2002) J. Biol. Chem. 277, 24753–24763[Abstract/Free Full Text]
  13. Sokol, S. Y., Li, Z., and Sacks, D. B. (2001) J. Biol. Chem. 276, 48425–48430[Abstract/Free Full Text]
  14. Li, Z., Kim, S. H., Higgins, J. M., Brenner, M. B., and Sacks, D. B. (1999) J. Biol. Chem. 274, 37885–37892[Abstract/Free Full Text]
  15. Briggs, M. W., Li, Z., and Sacks, D. B. (2002) J. Biol. Chem. 277, 7453–7465[Abstract/Free Full Text]
  16. Yu, J. Y., DeRuiter, S. L., and Turner, D. L. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 6047–6052[Abstract/Free Full Text]
  17. Brummelkamp, T., Bernards, R., and Agami, R. (2002) Cancer Cell 2, 243[CrossRef][Medline] [Order article via Infotrieve]
  18. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8392–8396[Abstract/Free Full Text]
  19. Kim, S. H., Li, Z., and Sacks, D. B. (2000) J. Biol. Chem. 275, 36999–37005[Abstract/Free Full Text]
  20. Allen, W. E., Zicha, D., Ridley, A. J., and Jones, G. E. (1998) J. Cell Biol. 141, 1147–1157[Abstract/Free Full Text]
  21. Keely, P. J. (2001) Methods Enzymol. 333, 256–266[Medline] [Order article via Infotrieve]
  22. McCallum, S. J., Erickson, J. W., and Cerione, R. A. (1998) J. Biol. Chem. 273, 22537–22544[Abstract/Free Full Text]
  23. Mathew, A. C., Rajah, T. T., Hurt, G. M., Abbas Abidi, S. M., Dmytryk, J. J., and Pento, J. T. (1997) Clin. Exp. Metastasis. 15, 393–399[CrossRef][Medline] [Order article via Infotrieve]
  24. Banyard, J., Anand-Apte, B., Symons, M., and Zetter, B. R. (2000) Oncogene 19, 580–591[CrossRef][Medline] [Order article via Infotrieve]
  25. O'Connor, K. L., Nguyen, B. K., and Mercurio, A. M. (2000) J. Cell Biol. 148, 253–258[Abstract/Free Full Text]
  26. Sachdev, P., Zeng, L., and Wang, L. H. (2002) J. Biol. Chem. 277, 17638–17648[Abstract/Free Full Text]
  27. Wojciak-Stothard, B., and Ridley, A. J. (2003) J. Cell Biol. 161, 429–439[Abstract/Free Full Text]
  28. Tuschl, T. (2002) Nat. Biotechnol. 20, 446–448[CrossRef][Medline] [Order article via Infotrieve]
  29. Brill, S., Li, S., Lyman, C. W., Church, D. M., Wasmuth, J. J., Weissbach, L., Bernards, A., and Snijders, A. J. (1996) Mol. Cell. Biol. 16, 4869–4878[Abstract]
  30. Keely, P. J., Westwick, J. K., Whitehead, I. P., Der, C. J., and Parise, L. V. (1997) Nature 390, 632–636[CrossRef][Medline] [Order article via Infotrieve]
  31. Kuroda, S., Fukata, M., Nakagawa, M., Fujii, K., Nakamura, T., Ookubo, T., Izawa, I., Nagase, T., Nomura, N., Tani, H., Shoji, I., Matsuura, Y., Yonehara, S., and Kaibuchi, K. (1998) Science 281, 832–835[Abstract/Free Full Text]
  32. Clark, E. A., Golub, T. R., Lander, E. S., and Hynes, R. O. (2000) Nature 406, 532–535[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Biol.Home page
M. Sakurai-Yageta, C. Recchi, G. Le Dez, J.-B. Sibarita, L. Daviet, J. Camonis, C. D'Souza-Schorey, and P. Chavrier
The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA
J. Cell Biol., June 16, 2008; 181(6): 985 - 998.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Jadeski, J. M. Mataraza, H.-W. Jeong, Z. Li, and D. B. Sacks
IQGAP1 Stimulates Proliferation and Enhances Tumorigenesis of Human Breast Epithelial Cells
J. Biol. Chem., January 11, 2008; 283(2): 1008 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. S. Dise, M. R. Frey, R. H. Whitehead, and D. B. Polk
Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G276 - G285.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
Y. A. Komarova, D. Mehta, and A. B. Malik
Dual Regulation of Endothelial Junctional Permeability
Sci. Signal., November 13, 2007; 2007(412): re8 - re8.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Brown, L. Bry, Z. Li, and D. B. Sacks
IQGAP1 Regulates Salmonella Invasion through Interactions with Actin, Rac1, and Cdc42
J. Biol. Chem., October 12, 2007; 282(41): 30265 - 30272.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-W. Jeong, Z. Li, M. D. Brown, and D. B. Sacks
IQGAP1 Binds Rap1 and Modulates Its Activity
J. Biol. Chem., July 13, 2007; 282(28): 20752 - 20762.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-G. Ren, Z. Li, and D. B. Sacks
IQGAP1 modulates activation of B-Raf
PNAS, June 19, 2007; 104(25): 10465 - 10469.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S.-W. Dessie, F. Rings, M. Holker, M. Gilles, D. Jennen, E. Tholen, V. Havlicek, U. Besenfelder, V. L Sukhorukov, U. Zimmermann, et al.
Dielectrophoretic behavior of in vitro-derived bovine metaphase II oocytes and zygotes and its relation to in vitro embryonic developmental competence and mRNA expression pattern
Reproduction, May 1, 2007; 133(5): 931 - 946.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Balenci, Y. Saoudi, D. Grunwald, J. C. Deloulme, A. Bouron, A. Bernards, and J. Baudier
IQGAP1 Regulates Adult Neural Progenitors In Vivo and Vascular Endothelial Growth Factor-Triggered Neural Progenitor Migration In Vitro
J. Neurosci., April 25, 2007; 27(17): 4716 - 4724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sharma and B. R. Henderson
IQ-domain GTPase-activating Protein 1 Regulates beta-Catenin at Membrane Ruffles and Its Role in Macropinocytosis of N-cadherin and Adenomatous Polyposis Coli
J. Biol. Chem., March 16, 2007; 282(11): 8545 - 8556.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. E. Siegrist and C. Q. Doe
Microtubule-induced cortical cell polarity
Genes & Dev., March 1, 2007; 21(5): 483 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Wang, T. Watanabe, J. Noritake, M. Fukata, T. Yoshimura, N. Itoh, T. Harada, M. Nakagawa, Y. Matsuura, N. Arimura, et al.
IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth
J. Cell Sci., February 15, 2007; 120(4): 567 - 577.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. B. Bensenor, H.-M. Kan, N. Wang, H. Wallrabe, L. A. Davidson, Y. Cai, D. A. Schafer, and G. S. Bloom
IQGAP1 regulates cell motility by linking growth factor signaling to actin assembly
J. Cell Sci., February 15, 2007; 120(4): 658 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Le Clainche, D. Schlaepfer, A. Ferrari, M. Klingauf, K. Grohmanova, A. Veligodskiy, D. Didry, D. Le, C. Egile, M.-F. Carlier, et al.
IQGAP1 Stimulates Actin Assembly through the N-Wasp-Arp2/3 Pathway
J. Biol. Chem., January 5, 2007; 282(1): 426 - 435.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Szczur, H. Xu, S. Atkinson, Y. Zheng, and M.-D. Filippi
Rho GTPase CDC42 regulates directionality and random movement via distinct MAPK pathways in neutrophils
Blood, December 15, 2006; 108(13): 4205 - 4213.
[Abstract] [Full Text] [PDF]


Home page